Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?
about
Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis.Some clinical features of liver cell failure: an appraisal of their causesMechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defectInsulin resistance and chronic liver disease.Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma.Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.Glucose, insulin and C-peptide kinetics during an oral glucose tolerance test in patients with chronic liver disease.Kinetics of human connecting peptide in normal and diabetic subjects.Interaction between hepatitis C virus and metabolic factors.Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?Outcomes in patients with diabetes 10 years after liver transplantation.Effects of changes in acid base and calcium concentration on fasting serum insulin, proinsulin, and glucose concentrations.Amino acids in liver disease.C-peptide measurement: methods and clinical utility.Hyperinsulinemia and hyperglucagonemia in fasted rats during liver regeneration.A study on the hyperinsulinism of late pregnancy.Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin.Endotoxin-induced hyperinsulinemia and hyperglucagonemia after experimental liver injury.Characterization of insulin secretion in Valproate-treated patients with epilepsy.Transient abnormality in carbohydrate metabolism during enterically transmitted non-A, non-B acute viral hepatitis.Insulin and C-peptide in ascitic fluid and plasma and their relative responses to glucagon in patients with cirrhosis.C-peptide in non-alcoholic cirrhosis and hepatocellular carcinoma.A study of beta-cell function after glucagon stimulation in thalassaemia major treated by high transfusion programme.Hypersecretion of proinsulin does not explain the hyperinsulinaemia of patients with liver cirrhosis.Hyperinsulinaemia and insulin resistance of cirrhosis: the importance of insulin hypersecretion.Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.Correlation between exocrine pancreatic secretion and serum concentration of human pancreatic polypeptide in chronic pancreatitis.The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring.Glucoregulation in acute liver failure.
P2860
Q34193422-E6E7A71B-2A94-4531-AC47-4E1B23FA67CEQ34474407-0AF88979-4A8D-4AE4-B6A6-165EB6739D21Q34628137-B2DC1B3B-B259-415D-9501-EFF34085EC93Q35073012-D6BC2740-6D78-4C26-ACC1-242E2C9033EAQ35594730-5FC638F1-1F8B-4CAE-AEF9-545777FADF6BQ35595227-D9452EEB-DEEF-4E2E-9B28-07A8B2689691Q35948276-251673B1-C817-4798-B87A-CD992E87D714Q37030191-0BA46C32-C5C2-4F57-A4CC-5DEE80D8EAE9Q37654443-01DEA8D6-A39A-483B-AB5E-DE736560CA67Q39036315-83CB18CB-89D6-49F7-8912-928FF2EDF095Q39047482-1A700EFA-D451-48C0-94F8-1C40BFA76AB8Q39659512-87ED070E-A52C-4EB6-8227-3505F19F72F1Q40166987-36167169-3F9F-42D7-B45B-2D43EF8607ADQ40177468-F4B2A1F3-8ED5-4FDC-8FCA-553E7C9AD1A3Q42467020-4A93A846-7EC6-4A9D-9422-D7E12515E31EQ42469814-3E3C087B-0D9D-4147-9C52-AE1920133FD0Q42726072-0FE9368E-9C7C-4C7E-820F-46AEBC2BA98FQ50215632-DC63861E-432A-4880-B89B-93934D417778Q51489539-B5F161E6-D015-431B-BB5A-654613647525Q51619892-C201B406-921B-4D4B-A39A-5F4D7C569CC1Q51623806-748AC13D-5002-4745-9C92-5658BD84F6E3Q51625868-C6070F43-AA87-4EFB-BFC6-AAA496C3216BQ51628401-EDA51D01-3AE1-45A3-A73E-EE7FF92A716AQ51632622-CE39E409-A4F7-4DCA-9564-12E744EFD2D0Q51640660-BFC5F431-699A-403E-AA72-A53F04C653C7Q51656635-59CAC32B-9E56-4834-8183-8F3F04004C9DQ51660510-C39E7126-64EE-4467-B56F-4A269760A663Q53071821-AF0AED97-7826-420D-B541-11CFB4085A51Q53698891-AC52F9E6-1A32-4BC9-8CC9-8475AB8A7791Q54427480-0F05CBF2-7DB5-4920-88B9-1958142E95D4
P2860
Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?
@en
Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?
@nl
type
label
Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?
@en
Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?
@nl
prefLabel
Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?
@en
Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?
@nl
P2093
P1433
P1476
Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?
@en
P2093
D G Johnson
K G Alberti
P356
10.1016/S0140-6736(77)91652-X
P407
P577
1977-01-01T00:00:00Z